PROGRAMME
08:30
Registration and Coffee in the Networking Surgery
09:25
Chair's Opening Address
Professor Graham Lord (confirmed)
Director, NIHR Comprehensive Biomedical Research Centre, Guy's and St Thomas' Hospital and King's College London
Professor Graham Lord (confirmed)
Director, NIHR Comprehensive Biomedical Research Centre, Guy's and St Thomas' Hospital and King's College London
09:30
Keynote Address
George Freeman MP (confirmed)
Government Life Sciences Adviser and Member of Parliament for Mid Norfolk
“Planning for growth”
Healthcare and life sciences are central to the government's Plan for Growth, and actions to support the strong relationship between the NHS and industry and their potential to stimulate economic growth have been set out in the recent Life Sciences Strategy. Close collaboration across sectors is essential in ensuring success.
George Freeman MP (confirmed)
Government Life Sciences Adviser and Member of Parliament for Mid Norfolk
“Planning for growth”
Healthcare and life sciences are central to the government's Plan for Growth, and actions to support the strong relationship between the NHS and industry and their potential to stimulate economic growth have been set out in the recent Life Sciences Strategy. Close collaboration across sectors is essential in ensuring success.
09:50
George Leahy (confirmed)
Deputy Director - Innovation, Department of Health
“A strategic approach to innovation in the reformed NHS”
Whilst the NHS is recognised as a world leader at invention, it is less successful at spreading them at pace and scale. How can innovation be properly incentivised? The NHS Chief Executive review set out to establish what behaviours and cultures stand in the way of innovation, and how they can be tackled effectively.
View Presentation
Deputy Director - Innovation, Department of Health
“A strategic approach to innovation in the reformed NHS”
Whilst the NHS is recognised as a world leader at invention, it is less successful at spreading them at pace and scale. How can innovation be properly incentivised? The NHS Chief Executive review set out to establish what behaviours and cultures stand in the way of innovation, and how they can be tackled effectively.
View Presentation
10:10
Professor Robert Lechler (confirmed)
Executive Director, King's Health Partners
“Collaboration for success”
Translating research into healthcare improvements and enhancing economic prosperity are key priorities for the UK. Supporting collaborative research between academia, industry and the NHS – which can create unique opportunities for research, offering linked information on treatment and outcomes on a large scale – is vitally important.
View Presentation
Executive Director, King's Health Partners
“Collaboration for success”
Translating research into healthcare improvements and enhancing economic prosperity are key priorities for the UK. Supporting collaborative research between academia, industry and the NHS – which can create unique opportunities for research, offering linked information on treatment and outcomes on a large scale – is vitally important.
View Presentation
10:30
Main Sponsor
Dr Jonathan Tedds (confirmed)
Senior Research Liaison Manager, University of Leicester
“Bridging biomedical research & healthcare with BRISSkit: Biomedical research data in the cloud?”
BRISSkit aims to bridge the divide between biomedical research and healthcare by providing secure, reliable and affordable open source database hosting solutions in-house or as a national cloud based service over the UK JANET academic network or NHS N3 cloud when available. The solutions will support the management and integration of tissue samples with clinical data and electronic patient records, having appropriate information governance and anonymisation where required.
View Presentation
Dr Jonathan Tedds (confirmed)
Senior Research Liaison Manager, University of Leicester
“Bridging biomedical research & healthcare with BRISSkit: Biomedical research data in the cloud?”
BRISSkit aims to bridge the divide between biomedical research and healthcare by providing secure, reliable and affordable open source database hosting solutions in-house or as a national cloud based service over the UK JANET academic network or NHS N3 cloud when available. The solutions will support the management and integration of tissue samples with clinical data and electronic patient records, having appropriate information governance and anonymisation where required.
View Presentation
10:45-10:55
Question and Answer Session
11:00
Masterclass Session 1
A series of Masterclasses will run throughout the day. You have the opportunity to pick a stream from the following three topics: Learning from the best, Research and development, and Chronic conditions.
A series of Masterclasses will run throughout the day. You have the opportunity to pick a stream from the following three topics: Learning from the best, Research and development, and Chronic conditions.
11:45
Coffee in the Networking Surgery
12:30
Masterclass Session 2
13:15
Lunch in the Networking Surgery
14:15
Masterclass Session 3
15:00
Coffee in the Networking Surgery
15:30
Chair's Afternoon Address
15:35
Keynote Address
Professor Sir John Tooke (confirmed)
President, Academy of Medical Sciences
“Simplifying health research regulation”
Health research regulation has grown increasingly complex, stifling research and driving some medical science overseas. Following a report by the Academy of Medical Sciences, a new health research regulatory agency is to be set up to streamline regulation and improve the cost-effectiveness of clinical trials.
View Presentation
Professor Sir John Tooke (confirmed)
President, Academy of Medical Sciences
“Simplifying health research regulation”
Health research regulation has grown increasingly complex, stifling research and driving some medical science overseas. Following a report by the Academy of Medical Sciences, a new health research regulatory agency is to be set up to streamline regulation and improve the cost-effectiveness of clinical trials.
View Presentation
15:55
Alasdair Gaw (confirmed)
Lead Specialist, Stratified Medicine, Technology Strategy Board
“Making the UK the best place to develop and adopt Stratified Medicine”
Stratified Medicine is recognised as the future of healthcare treatment worldwide. The UK Stratified Medicine Innovation Platform is a consortium of government bodies and leading charities from the Department of Health, Scottish Government Health Directorate, NICE, MRC, Cancer Research UK and Arthritis Research UK with the Technology Strategy Board to increase the impact of R&D investment and make the UK a leader in the development and implementation of Stratified Medicine. Technology Strategy Board is committed to identifying and investing in Stratified Medicine opportunities that will supporting the growth and further development of the UK healthcare industry.
View Presentation
Lead Specialist, Stratified Medicine, Technology Strategy Board
“Making the UK the best place to develop and adopt Stratified Medicine”
Stratified Medicine is recognised as the future of healthcare treatment worldwide. The UK Stratified Medicine Innovation Platform is a consortium of government bodies and leading charities from the Department of Health, Scottish Government Health Directorate, NICE, MRC, Cancer Research UK and Arthritis Research UK with the Technology Strategy Board to increase the impact of R&D investment and make the UK a leader in the development and implementation of Stratified Medicine. Technology Strategy Board is committed to identifying and investing in Stratified Medicine opportunities that will supporting the growth and further development of the UK healthcare industry.
View Presentation
16:15
Richard Stubbs (confirmed)
Director of Implementation and Interim Managing Director, NHS Global
“Going global – promoting UK healthcare innovation”
The government's 'Plan for Growth' recognises the reputation of the NHS and the UK life sciences sector internationally as a great asset, and sets out the intention to establish a 'proactive, entrepreneurial' NHS Global to make the most of the brand overseas and to offer support and advice to NHS Trusts.
View Presentation
Director of Implementation and Interim Managing Director, NHS Global
“Going global – promoting UK healthcare innovation”
The government's 'Plan for Growth' recognises the reputation of the NHS and the UK life sciences sector internationally as a great asset, and sets out the intention to establish a 'proactive, entrepreneurial' NHS Global to make the most of the brand overseas and to offer support and advice to NHS Trusts.
View Presentation
16:35
Question and Answer Session
16:50
Chair's Closing Remarks
17:00
Event Close
